Fluoride PET/CT Whole Body There is limited evidence to support the use of fluoride PET/CT for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically. MRI Abdomen and Pelvis Without and With IV Contrast There is limited evidence to support the use of MRI abdomen and pelvis without and with IV contrast for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically. Pretreatment Detection of Prostate Cancer MRI Abdomen and Pelvis Without IV Contrast There is limited evidence to support the use of MRI abdomen and pelvis without IV contrast for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically. MRI Pelvis Without IV Contrast In patients with clinically suspected prostate cancer who had a negative TRUS-guided biopsy, imaging without using IV contrast is also a viable option based on the identical rationales for using MRI of the pelvis with IV contrast [29,40,44,45,49]. Nevertheless, controversies exist with regard to balancing between the small incremental yield for detecting clinically significant cancer using IV contrast and potential benefits such as decreased scan time when forgoing IV contrast [50-54]. MRI Whole Body Without and With IV Contrast There is limited evidence to support the use of MRI whole body without and with IV contrast for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically.
Pretreatment Detection Surveillance and Staging of Prostate Cancer. Fluoride PET/CT Whole Body There is limited evidence to support the use of fluoride PET/CT for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically. MRI Abdomen and Pelvis Without and With IV Contrast There is limited evidence to support the use of MRI abdomen and pelvis without and with IV contrast for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically. Pretreatment Detection of Prostate Cancer MRI Abdomen and Pelvis Without IV Contrast There is limited evidence to support the use of MRI abdomen and pelvis without IV contrast for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically. MRI Pelvis Without IV Contrast In patients with clinically suspected prostate cancer who had a negative TRUS-guided biopsy, imaging without using IV contrast is also a viable option based on the identical rationales for using MRI of the pelvis with IV contrast [29,40,44,45,49]. Nevertheless, controversies exist with regard to balancing between the small incremental yield for detecting clinically significant cancer using IV contrast and potential benefits such as decreased scan time when forgoing IV contrast [50-54]. MRI Whole Body Without and With IV Contrast There is limited evidence to support the use of MRI whole body without and with IV contrast for initial imaging of patients with clinically suspected prostate cancer unless or until the presence of higher-risk disease has been established histologically.